article Developing respiratory therapeutics for prophylaxis and treatment 30 April 2020 | By Hannah Balfour (Drug Target Review) Drug Target Review explores antiviral Fc-conjugates and how they could be used as a COVID-19 prophylactic and therapeutic with Dr Jeff Stein, Cidara’s President and CEO.
news New imaging technique developed to study fungi 9 April 2020 | By Victoria Rees (Drug Target Review) German researchers have developed a novel imaging technique called expansion microscopy (ExM) to investigate fungi samples.
news Screening reveals rocaglate compounds kill C. auris 26 March 2020 | By Victoria Rees (Drug Target Review) Researchers have screened over 2,000 compounds to discover that rocaglates effectively combat C. auris, offering a potential new treatment.
news Metal-containing compounds could lead to new antibacterials 2 March 2020 | By Hannah Balfour (Drug Target Review) International collaboration has shown that compounds with metals in them show antibacterial activity against MRSA, E. coli and A. baumannii.
news F2G raises $60m to develop novel antifungal therapies 20 June 2016 | By Victoria White, Digital Content producer F2G Ltd has raised $60 million in financing to develop its pipeline of novel therapies to treat life threatening invasive fungal infections...
news Cypralis appoints a new Chief Scientific Officer 2 March 2016 | By Victoria White Cypralis, a company focussed on the discovery of novel therapeutics based on modulation of PPIases, has appointed Dr Michael Peel as Chief Scientific Officer...
news MGB Biopharma and Strathclyde to develop new MGB anti-infectives 16 February 2016 | By Victoria White MGB Biopharma and the University of Strathclyde are to extend their existing collaboration to develop novel MGB anti-infectives...
news FDA grants QIDP and Fast Track Designations to CD101 IV for the treatment of candidemia 11 May 2015 | By Victoria White Cidara Therapeutics has announced that the FDA has designated the Company’s lead antifungal product candidate, CD101 IV, as a QIDP with Fast Track status...